Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07478198Not ApplicableEnrolling By Invitation

Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy

Role: lead

NCT07165158Phase 4Not Yet Recruiting

The Effect of Semaglutide on Bone Health

Role: collaborator

NCT06512090Not ApplicableNot Yet Recruiting

Effects of LGI Steam Bread on Glycemia Control in T2DM in China

Role: lead

All 3 trials loaded